Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

218.330.00 0.00%
The 24 analysts offering 1 year price forecasts for ALNY have a max estimate of — and a min estimate of —.

Analyst rating

Based on 30 analysts giving stock ratings to ALNY in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

ALNY EPS for the last quarter is −1.10 USD despite the estimation of −1.19 USD. In the next quarter EPS is expected to reach −1.12 USD. Track more of Alnylam Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Alnylam Pharmaceuticals, Inc. revenue is expected to reach ‪428.01 M‬ USD. Check out Alnylam Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, ALNY price target is 218.33 USD with a max estimate of 395.00 USD and a min estimate of 136.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with ALNY news and stock market news.
We've gathered opinions of 30 analysts rating ALNY stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.